Why-data-monopoly-in-life-sciences-is-not-beneficial

Why data monopoly in life sciences is not beneficial?

The pharma industry is one which is responsible for millions of lives. In 2018, the United States spent nearly 18% of GDP on healthcare. Moreover, the country spends more than U.S. $71 billion on Research & Development in pharma annually. According to statista, this figure is expected to increase to over 200 billion U.S. dollars …

Why data monopoly in life sciences is not beneficial? Read More »